Trial intelligence / Profile preview

Amino Acid Peritoneal Dialysis Fluid in Diabetes

NCT07077538Recruiting

Sponsor
Gaozhou People's Hospital
Start
Jul 2025
Primary completion
Jun 2026
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Open-label, single-arm trial of amino acid peritoneal dialysis solution in end stage renal disease (ESRD), sponsored by Gaozhou People's Hospital. Primary endpoint: Glycosylated Hemoglobin at Day 90. Started Jul 2025; status: recruiting.

02

Drugs

amino acid peritoneal dialysis solution
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT07077538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07077538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call